Literature DB >> 11336128

Transient pseudohypoparathyroidism and neonatal seizure.

S Manzar1.   

Abstract

The case of a neonate is presented who had late onset seizure associated with hypocalcemia, hyperphosphatemia, and raised parathyroid hormone. The infant did not have any stigmata of pseudohypoparathyroidism. The hypocalcemia was initially resistant to calcium therapy, but responded to vitamin D analog therapy. The diagnosis of 'transient neonatal pseudohypoparathyroidism' was entertained, as the infant remained stable and seizure-free with normal serum biochemistry during 8 months of follow-up.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11336128     DOI: 10.1093/tropej/47.2.113

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  4 in total

1.  Postnatal establishment of allelic Gαs silencing as a plausible explanation for delayed onset of parathyroid hormone resistance owing to heterozygous Gαs disruption.

Authors:  Serap Turan; Eduardo Fernandez-Rebollo; Cumhur Aydin; Teuta Zoto; Monica Reyes; George Bounoutas; Min Chen; Lee S Weinstein; Reinhold G Erben; Vladimir Marshansky; Murat Bastepe
Journal:  J Bone Miner Res       Date:  2014-03       Impact factor: 6.741

2.  Calcinosis cutis in a newborn with transient pseudohypoparathyroidism.

Authors:  Hacer Ergin; Abdullah Karaca; Seniz Ergin; Nergül Cördük; Nevzat Karabulut
Journal:  Indian J Pediatr       Date:  2011-05-25       Impact factor: 1.967

3.  Neonatal pseudohypoparathyroidism.

Authors:  Manish Narang; Rashim Salota; Sudeep Singh Sachdev
Journal:  Indian J Pediatr       Date:  2006-01       Impact factor: 1.967

4.  The G protein α subunit variant XLαs promotes inositol 1,4,5-trisphosphate signaling and mediates the renal actions of parathyroid hormone in vivo.

Authors:  Qing He; Yan Zhu; Braden A Corbin; Antonius Plagge; Murat Bastepe
Journal:  Sci Signal       Date:  2015-08-25       Impact factor: 8.192

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.